Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nu-Med Plus's operating income for the twelve months ending Jun 30, 2026 was -$55.54K. For fiscal 2025 it was -$48.96K. The highest annual figure on record is -$48.96K in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.96K | – |
| FY2024 | Dec 31, 2024 | -$63.33K | – |
| FY2023 | Dec 31, 2023 | -$120.53K | – |
| FY2022 | Dec 31, 2022 | -$182.17K | – |
| FY2021 | Dec 31, 2021 | -$839.45K | – |
| FY2020 | Dec 31, 2020 | -$1.99M | – |
| FY2019 | Dec 31, 2019 | -$1.02M | – |
| FY2018 | Dec 31, 2018 | -$1.17M | – |
| FY2017 | Dec 31, 2017 | -$466.52K | – |
| FY2016 | Dec 31, 2016 | -$1.22M | – |
| FY2015 | Dec 31, 2015 | -$946.48K | – |
| FY2014 | Dec 31, 2014 | -$1.15M | – |
| FY2013 | Dec 31, 2013 | -$233.64K | – |
| FY2012 | Dec 31, 2012 | -$258.23K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$22.56K | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.15K | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.76K | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.08K | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.42K | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.70K | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.29K | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.42K | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.04K | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.58K | – |
| Q4 FY2023 | Dec 31, 2023 | -$55.34K | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.15K | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.07K | – |
| Q1 FY2023 | Mar 31, 2023 | -$26.97K | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.39K | – |
| Q3 FY2022 | Sep 30, 2022 | -$58.05K | – |
| Q2 FY2022 | Jun 30, 2022 | -$58.07K | – |
| Q1 FY2022 | Mar 31, 2022 | -$59.65K | – |
| Q4 FY2021 | Dec 31, 2021 | -$112.34K | – |
| Q3 FY2021 | Sep 30, 2021 | -$118.37K | – |
| Q2 FY2021 | Jun 30, 2021 | -$251.99K | – |
| Q1 FY2021 | Mar 31, 2021 | -$356.75K | – |
| Q4 FY2020 | Dec 31, 2020 | -$491.16K | – |
| Q3 FY2020 | Sep 30, 2020 | -$449.76K | – |
| Q2 FY2020 | Jun 30, 2020 | -$904.45K | – |
| Q1 FY2020 | Mar 31, 2020 | -$149.31K | – |
| Q4 FY2019 | Dec 31, 2019 | -$205.70K | – |
| Q3 FY2019 | Sep 30, 2019 | -$146.21K | – |
| Q2 FY2019 | Jun 30, 2019 | -$243.79K | – |
| Q1 FY2019 | Mar 31, 2019 | -$423.73K | – |
| Q4 FY2018 | Dec 31, 2018 | -$335.97K | – |
| Q3 FY2018 | Sep 30, 2018 | -$522.07K | – |
| Q2 FY2018 | Jun 30, 2018 | -$168.71K | – |
| Q1 FY2018 | Mar 31, 2018 | -$142.56K | – |
| Q2 FY2017 | Jun 30, 2017 | -$111.30K | – |
| Q1 FY2017 | Mar 31, 2017 | -$69.73K | – |
See a number that looks wrong?